Hofseth BioCare ASA (OSTO:HBCO) Short-Term Capital Lease Obligation : kr0.0 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hofseth BioCare ASA Short-Term Capital Lease Obligation?

Hofseth BioCare ASA's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was kr0.0 Mil.

Hofseth BioCare ASA's quarterly Short-Term Capital Lease Obligation increased from Sep. 2024 (kr0.0 Mil) to Dec. 2024 (kr11.2 Mil) but then declined from Dec. 2024 (kr11.2 Mil) to Mar. 2025 (kr0.0 Mil).

Hofseth BioCare ASA's annual Short-Term Capital Lease Obligation declined from Dec. 2022 (kr12.9 Mil) to Dec. 2023 (kr10.8 Mil) but then increased from Dec. 2023 (kr10.8 Mil) to Dec. 2024 (kr11.2 Mil).

Hofseth BioCare ASA Short-Term Capital Lease Obligation Historical Data

The historical data trend for Hofseth BioCare ASA's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hofseth BioCare ASA Short-Term Capital Lease Obligation Chart

Hofseth BioCare ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

8.22

12.10

12.86

10.79

11.22

Hofseth BioCare ASA Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	11.22	-

Hofseth BioCare ASA Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Hofseth BioCare ASA Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Hofseth BioCare ASA's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Hofseth BioCare ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hofseth BioCare ASA (OSTO:HBCO) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

HOFBF:USA HBC:Norway 0Q6H:UK HBQ:Germany

Address

Keiser Wilhelms Gate 24, Aalesund, NOR, 6003

Website

https://www.hofsethbiocare.com

Hofseth BioCare ASA is a Norway-based company engaged in the business of developing, manufacturing, marketing, and selling marine ingredients such as oil, calcium, and protein products. Its products and their respective brands include salmon oil (OmeGo), hydrolyzed soluble protein (ProGo), Calcium/Collagen (CalGo or NT-II), and non-soluble protein (PetGo), all of which are produced in the Midsund plant. The firm sells its products to various segments of the human nutrition market, such as sports nutrition, supplements, and health foods, as well as to the market within nutrition for the pet and feed industry. It generates maximum revenue from the sale of salmon oil. Geographically, the company generates maximum revenue from Europe, followed by North America and Asia.

Hofseth BioCare ASA Headlines

No Headlines